PR View by John Seng

Share this article:
The word transparency resonates with communications professionals, accountants, auditors and marketers alike. But there's another domain to introduce this word into: RFPs to PR agencies.
Each year, we read and respond to scores of requests for capabilities, strategic thinking and big, “outside-the-box” ideas. Companies that take the guesswork out of the public relations bidding process in advance are more likely to enjoy long-term, winning partnerships. That “share more-win bigger” philosophy usually shows up in the very first step of competition: a well-run agency brief.

Most companies still take the well-traveled road—querying candidates, selecting qualifiers, providing background and a market research presentation, and then waiting for cinematic presentations to blow you away.

But the best start to identifying the ideal communications partner involves a different approach. At the outset, clients should return to scheduling one-on-one briefings with prospective agencies to encourage a dialogue and get a feel for the people they may be working with. Use this time to toss out hypothetical scenarios. Encourage brainstorming—allowing time for questions and “bubble-up” concepts to be addressed. Briefing calls or meetings with multiple candidate firms deny you the opportunity to begin to gauge a potential partnership from the outset.

Of course transparency is critical in sharing both product attributes and potential challenges. An honest assessment and frank exchange will spawn ideas that overcome obstacles. Finally, don't shy away from sharing realistic budget parameters and a sense of your company's view on the role of PR in the marketing mix.

It's clear—increased transparency is a win for clients.

John Seng is founder and president of Spectrum Science Communications, a health-only communications firm.

Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.